Therapeutic targeting of p53: all mutants are equal, but some mutants are more equal than others

K Sabapathy, DP Lane - Nature reviews Clinical oncology, 2018 - nature.com
TP53, which encodes the tumour-suppressor protein p53, is the most frequently mutated
gene across all cancer types. The presence of mutant p53 predisposes to cancer …

The p53 pathway: positive and negative feedback loops

SL Harris, AJ Levine - Oncogene, 2005 - nature.com
The p53 pathway responds to stresses that can disrupt the fidelity of DNA replication and
cell division. A stress signal is transmitted to the p53 protein by post-translational …

A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1

Y Miki, J Swensen, D Shattuck-Eidens, PA Futreal… - Science, 1994 - science.org
A strong candidate for the 17q-linked BRCA1 gene, which influences susceptibility to breast
and ovarian cancer, has been identified by positional cloning methods. Probable …

hSIR2SIRT1 functions as an NAD-dependent p53 deacetylase

H Vaziri, SK Dessain, EN Eaton, SI Imai, RA Frye… - Cell, 2001 - cell.com
DNA damage-induced acetylation of p53 protein leads to its activation and either growth
arrest or apoptosis. We show here that the protein product of the gene hSIR2 SIRT1, the …

The role of nuclear lamin B1 in cell proliferation and senescence

T Shimi, V Butin-Israeli, SA Adam… - Genes & …, 2011 - genesdev.cshlp.org
Nuclear lamin B1 (LB1) is a major structural component of the nucleus that appears to be
involved in the regulation of many nuclear functions. The results of this study demonstrate …

Linking the p53 tumour suppressor pathway to somatic cell reprogramming

T Kawamura, J Suzuki, YV Wang, S Menendez… - Nature, 2009 - nature.com
Reprogramming somatic cells to induced pluripotent stem (iPS) cells has been
accomplished by expressing pluripotency factors and oncogenes,,,,,,,, but the low frequency …

[PDF][PDF] p53: puzzle and paradigm.

LJ Ko, C Prives - Genes & development, 1996 - scholar.archive.org
As the tale of p53 unfolds, it becomes ever more intriguing. Although our understanding of
the critical and complex roles played by p53 is progressing rapidly, new findings continue to …

p53 is regulated by the lysine demethylase LSD1

J Huang, R Sengupta, AB Espejo, MG Lee, JA Dorsey… - Nature, 2007 - nature.com
Abstract p53, the tumour suppressor and transcriptional activator, is regulated by numerous
post-translational modifications, including lysine methylation,. Histone lysine methylation …

Single-chromosome gains commonly function as tumor suppressors

JM Sheltzer, JH Ko, JM Replogle, NCH Burgos… - Cancer cell, 2017 - cell.com
Aneuploidy is a hallmark of cancer, although its effects on tumorigenesis are unclear. Here,
we investigated the relationship between aneuploidy and cancer development using cells …

Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome

A Sigal, V Rotter - Cancer research, 2000 - AACR
The p53 guardian of the genome is inactivated in the majority of cancers, mostly through
missense mutations that cause single residue changes in the DNA binding core domain of …